Sunshield Chemicals Rights Issue 2025 Date, Price, Allotment, Ratio

Sunshield Chemicals Rights issue date is fixed, the rights issue is to open on September 30, 2025 and will close on October 24, 2025. The Sunshield Chemicals Rights issue record date is September 24, 2025. The company is to offer 14,41,776 equity shares at a price of ₹901 per share. The Sunshield Chemicals Rights issue size will be ₹129.90 Crores. The entitlement ratio is 10:51, 10 rights share for every 51 fully-paid equity shares held on the record date. Check out Sunshield Chemicals rights issue details.

Sunshield Chemicals About us

Sunshield Chemicals Limited, founded on 19 November 1986, is one of the leading companies involved in the manufacturing of specialty chemicals such as surfactants (including ethoxylates and propoxylates), antioxidants, HQEE, THEIC, and other functional chemical products. These chemicals are used in various applications such as coatings, agrochemicals, home & personal care, and industrial formulations across many sectors.

Sunshield Chemicals Limited holds ISO 9001 certification, showcasing its commitment to maintaining high-quality standards. The company is also equipped with a strong R&D/QC laboratory for continuous innovation. The modern manufacturing facility at Rasal allows its exporting presence globally. The company’s main aim is to follow innovation, regulatory compliance, and sustainable business practices for long-term growth.

Sunshield Chemicals Rights Issue Review

Sunshield Chemicals Rights Issue 2025 Dates & Time Table

Rights Issue Open:	September 30, 2025
Rights Issue Close:	October 24, 2025
Rights Record Date:	September 24, 2025
Last Date to Buy Shares:	September 23, 2025
Deemed Date of Allotment	October 28, 2025
Renunciation of Rights Entitlements	October 16, 2025

Sunshield Chemicals Rights Issue 2025 Offer Details

Rights Issue Size:	Approx ₹129.90 Crores
Price Band:	₹901 Per Equity Share
Face Value:	₹10 Per Equity Share
Listing on:	BSE
Entitlement Ratio:	10:51 (10 rights share for every 51 shares)
Equity:	14,41,776 Equity Share
Letter of Offer:	Click Here
Application Form:	Click Here
Live Share Price:	Click Here

Sunshield Chemicals Rights Issue 2025 Form & How to Apply

You can apply for Sunshield Chemicals Rights Issue 2025 in two ways:

Net Banking (ASBA)
Registrar’s Website (R-WAP Facility)

Sunshield Chemicals Financial Report

₹ in Crores
Year	Revenue	Expense	PAT
2023	₹246.58	₹227.49	₹13.66
2024	₹284.86	₹258.11	₹18.85
2025	₹368.94	₹350.89	₹14.58

Sunshield Chemicals Rights Issue 2025 Allotment Status

Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: [email protected]
Website: https://ipo.bigshareonline.com/ipo_status.html

Sunshield Chemicals Rights Issue 2025 Lead Managers

To Be Updated Soon

Company Address:

Sunshield Chemicals Ltd
1501-A, Universal Majestic,
P.L. Lokhande Marg
Behind R.B.K International Academy, Chembur
Mumbai, 400043
Phone: 910222555012
Email: [email protected]
Website: http://www.sunshieldchemicals.com/

Sunshield Chemicals Rights Issue 2025 FAQs:

When is Sunshield Chemicals Rights Issue 2025 Record Date?

Sunshield Chemicals Rights Issue 2025 record date is September 24, 2025.

What is Sunshield Chemicals Rights Issue 2025 Price?

The company has fixed the price at ₹901 per equity share.

What is the Sunshield Chemicals Rights Issue 2025 Ratio?

The company has fixed the ratio (10:51), 10 Rights Equity Share for every 51 Equity Shares as on record date.

How to apply for Sunshield Chemicals Rights Issue 2025?

As per the record date you need to have Sunshield Chemicals Rights shares in your Demat account. You can participate in Rights Issue via offline form download or you can apply online via ASBA or UPI options.

Follow IPO Watch for the Upcoming IPO News and their reviews, also keep following us on Twitter, Facebook, and Instagram. For our latest videos, subscribe to our YouTube channel.

Vijay Prajapati

An experienced stock market professional with expertise in IPO research, market insights, and equity strategies. With a strong background in research and capital markets, he delivers comprehensive coverage on upcoming IPOs, subscription patterns, grey market premium (GMP), and post-listing performance, along with detailed reviews, recommendations, and technical analysis.

Add IPOWatch to your Google News feed.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.